Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of March 14 Dividend Increases/Decreases for the Week of March 7 Dividend Increases/Decreases for the Week of February 28 Dividend Increases/Decreases for the Week of February 21 Dividend Increases/Decreases for the Week of February 14

Results 41 - 50 of 201 for hum. (0.31 seconds) Two Huge Deals as M&A Accelerates Smithfield sells itself and Valeant makes another splash... PetSmart Remains Overvalued Pet retailer PetSmart posted a strong quarter, and it... Evaluating the Industry Structure of Managed Care Organizations We take a look at the managed care organization (MCO) and... Inside AbbVie: A Look at a New Pharmaceutical Giant Let's take a look at Abbott's new standalone business,... LinkedIn Surges on Terrific Revenue Growth LinkedIn continues to be a darling in the social media... ASCO Reveals That Big Pharma Is Alive Some good news from Bristol-Myers Squibb, Merck,... Facebook and LinkedIn Early In Monetization; Neither a Bargain Facebook and LinkedIn have potential, but we think Google... Dividend Increases for the Week Ending April 17 Let's take a look at firms that raised their dividends... Looking for a Pullback to Pick Up Johnson & Johnson's Shares We think J&J's shares are fully-valued at this time,... Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities Big Pharma is not dead, but neither are the generics.... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next